DEAR MAYO CLINIC: I recently was diagnosed with vascular Ehlers-Danlos syndrome. My doctor said there's no cure and that it's genetic. What can be done to treat this? I have two young children. Should they be tested for it?
Apr 15, 2022
0
4
Omega-3 fatty acids, combined with two blood-thinning drugs, significantly changed the blood-clotting process and may reduce the risk of heart attacks in patients with stents in their heart arteries, according to research ...
May 26, 2011
0
1
In an effort to determine if stem cell therapy can prevent or improve a condition called "diabetic foot" caused by poor blood flow in patients with diabetes, a team of researchers in China has found that transplanting human ...
Aug 30, 2016
0
0
Researchers at the University of Michigan Kellogg Eye Center have identified a compound that could interrupt the chain of events that cause damage to the retina in diabetic retinopathy. The finding is significant because ...
Jul 27, 2012
0
0
Babies born prematurely who require treatment to prevent blindness from retinopathy of prematurity (ROP) could be treated with a dose of Avastin (bevacizumab) that is a fraction of the dose commonly used for ROP currently. ...
Apr 23, 2020
0
11
A unique collaboration between imaging science, vascular medicine and rehabilitation at Vanderbilt University Medical Center is transforming the diagnosis and treatment of lipedema, a debilitating, abnormal deposition of ...
Feb 17, 2023
0
7
There are more than 2 million people living with an amputation in the United States, with about 400 being added daily. For many of them, prostheses or artificial limbs are a part of their lives, and they need to relearn how ...
Sep 16, 2022
0
100
(HealthDay)—Home diabetes regimens partially explain the increased risk of having a hypoglycemia event during hospitalization among older African-American men with diabetes, according to a study published in the April issue ...
May 14, 2013
0
0
(Medical Xpress)—Tumours need a steady supply of sufficient nutrients to be able to grow. In order to secure the nutrient availability, they secrete messenger compounds to stimulate neighbouring blood vessels to proliferate ...
Mar 15, 2013
0
0
Data from the landmark HORIZONS-AMI clinical trial demonstrated that the administration of the anticoagulant medication bivalirudin enhanced survival compared to the use of heparin plus a glycoprotein (GP) IIb/IIIa inhibitor ...
Jun 13, 2011
0
1
